Focuses on the development and testing of new drugs for depression and schizophrenia. Enhancement of effectiveness of current medications; Implications for patients and prescribers; Role of serotonin in relieving depression.EBSCO_AspBrown University Psychopharmacology Update...
The findings of the Stanford scientists could open a new way to a new class of antidepressants that could have no side-effects and faster-acting functions than existing drugs today.
Several novel, mechanistically speaking, drugs for depression and schizophrenia are on the horizon and there is renewed interest on the part of both large and small biopharmaceutical companies to invest the necessary resources, intellectual and financial, required. While the field of psychiatry works ...
Despite a revolution in depression awareness and treatment in the 1990s and the approval of more than 20 drugs for the condition, many individuals still struggle with the condition. However, the recent discovery of new regions in the human genome associated with susceptibility to major depressive ...
Orexin Receptor Antagonists as Adjunct Drugs for the Treatment of Depression: A Mini Meta-Analysis Introduction: There is growing interest in the efficacy of orexin receptor antagonists (ORA), one of the new psychopharmacological agents used in the treat... UURLU, Mustafa - Archives of Neuropsychi...
Learn how these resilience-enhancing drugs could change the way we treat mental illness. science disease health medicine brain humanity depression mental
Over-the-Counter-Drugs for the Treatment of Mood and Anxiety Disorders -- The Views of German Pharmacists. Introduction: Depression, anxiety, agitation and sleep disorders are highly prevalent in the general population, but few persons receive psychiatric care. ... Hamann,J.,Linde,... - 《Phar...
Chronicdepressionis one of the most common forms of mental illness, and medical scientists have been hard at work searching for a cure. Most drugs used to treat the condition areserotonin reuptake inhibitorsthat reduce depression by targeting serotonin transporters—they are generically known as SERT...
Gepirone in the treatment of major depression. J Clin Psychopharmacol. 1990 Jun;10(3 Suppl):77S-85S. doi: 10.1097/00004714-199006001-00014. 3. Kaur Gill A, Bansal Y, Bhandari R, et al. Gepirone hydrochloride: a novel antidepressant with 5-HT1A agonistic properties. Drugs Today (Barc). ...
CNS Drugs 2001;15797- 817PubMedGoogle ScholarCrossref 38. McEwen BSAlves SE Estrogen actions in the central nervous system. Endocr Rev 1999;20279- 307PubMedGoogle Scholar 39. Rubinow DRSchmidt PJRoca CA Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 1998;...